Jacob A J, Sutherland G R, Bird A G, Brettle R P, Ludlam C A, McMillan A, Boon N A
Department of Cardiology, Royal Infirmary, Edinburgh.
Br Heart J. 1992 Dec;68(6):549-53. doi: 10.1136/hrt.68.12.549.
To determine the prevalence of and risk factors for myocardial dysfunction in HIV infection.
173 patients infected with HIV underwent echocardiography. 119 were current or previous injection drug users, 38 were homosexuals, 10 were haemophiliac patients, and six were heterosexual.
Detection of impaired ventricular function.
26 patients with abnormalities of ventricular size or function or both were identified. The abnormality was (a) dilated cardiomyopathy in 13 patients (eight homosexuals, three drug users, and two haemophiliacs) with a mean CD4 count of 38 cells/mm3, which accords with end-stage disease (in addition, three patients were identified as having borderline impairment of left ventricular function); (b) left ventricular dilatation without loss of function in a further six patients; and (c) isolated right ventricular dilation in seven patients. Follow up echocardiograms were obtained in 71 patients, 18 of whom had myocardial dysfunction (103 echocardiograms, mean (SD) 2.5 (0.6) scans per patient, mean interval 200 (116) days, range 14-538 days). These showed that in four cases of isolated right ventricular dilatation, one of isolated left ventricular dilatation, and two with borderline left ventricular dysfunction myocardial function subsequently reverted to normal. There was no excess of exposure to zidovudine in the patients with myocardial dysfunction. Similarly, patients with myocardial dysfunction had no serological evidence of excess secondary infection with Toxoplasma gondii and cytomegalovirus.
There was a high prevalence and wide range of myocardial dysfunction in HIV positive patients. Dilated cardiomyopathy was a feature of advanced HIV disease and affected all major risk groups for HIV infection. In contrast, isolated dilatation of either ventricle occurred at an earlier stage of HIV infection and, particularly in the case of the right ventricle, often was transient. Neither treatment with zidovudine nor infection with Toxoplasma gondii or cytomegalovirus seemed to be responsible for these findings.
确定HIV感染中心肌功能障碍的患病率及危险因素。
173例HIV感染者接受了超声心动图检查。其中119例为现用或曾用过注射毒品者,38例为同性恋者,10例为血友病患者,6例为异性恋者。
检测心室功能受损情况。
26例患者被发现存在心室大小或功能异常或两者均异常。异常情况包括:(a)13例患者(8例同性恋者、3例吸毒者和2例血友病患者)出现扩张型心肌病,平均CD4细胞计数为38个/mm³,符合终末期疾病(此外,3例患者被确定为左心室功能临界受损);(b)另有6例患者左心室扩张但功能未丧失;(c)7例患者出现孤立性右心室扩张。71例患者接受了随访超声心动图检查,其中18例存在心肌功能障碍(共103次超声心动图检查,平均(标准差)每位患者2.5(0.6)次检查,平均间隔200(116)天,范围14 - 538天)。这些检查显示,在4例孤立性右心室扩张、1例孤立性左心室扩张以及2例左心室功能临界受损的病例中,心肌功能随后恢复正常。心肌功能障碍患者中齐多夫定暴露量并无增加。同样,心肌功能障碍患者也没有弓形虫和巨细胞病毒继发感染过多的血清学证据。
HIV阳性患者中心肌功能障碍的患病率较高且范围广泛。扩张型心肌病是晚期HIV疾病的一个特征,影响了所有主要的HIV感染风险群体。相比之下,任何一个心室的孤立性扩张发生在HIV感染的早期阶段,特别是右心室的情况,通常是短暂的。齐多夫定治疗以及弓形虫或巨细胞病毒感染似乎都与这些发现无关。